Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | HTT | P42858 | 2/20 | 0.61 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 8/20 | 0.56 |
| ▸ | MEN1 | O00255 | 6/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | NPC1 | O15118 | 3/20 | 0.56 |
| ▸ | POLB | P06746 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | CASP6 | P55212 | 2/20 | 0.56 |
| ▸ | CTDSP1 | Q9GZU7 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.56 |
| ▸ | IDO1 | P14902 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3465399 | 1.00 | AKR1B1 (0.64) | AKR1B1LMNAHTTABCC4GAA | |
| SCHEMBL1633998 | 0.94 | CA2 (0.60) | AKR1B1LMNAHTTABCC4GAA | |
| SCHEMBL1633999 | 0.94 | CA2 (0.60) | AKR1B1LMNAHTTABCC4GAA | |
| SCHEMBL7204862 | 0.84 | MAPT (0.54) | AKR1B1LMNAHTTABCC4GAA | |
| SCHEMBL14476949 | 0.84 | MAPT (0.53) | AKR1B1LMNAHTTMAPTMEN1 | |
| SCHEMBL22637978 | 0.82 | CA2 (0.48) | AKR1B1LMNAHTTABCC4GAA | |
| SCHEMBL22637979 | 0.82 | CA2 (0.48) | AKR1B1LMNAHTTABCC4GAA | |
| SCHEMBL14462168 | 0.80 | MAPT (0.48) | LMNAHTTTSHRMAPTMEN1 | |
| Phenylacetic Acid SCHEMBL9449909 | 0.79 | AKR1B1 (1.00) | AKR1B1LMNAHTTABCC4GAA | |
| Phenylacetic Acid SCHEMBL1459 | 0.79 | AKR1B1 (1.00) | AKR1B1LMNAHTTABCC4GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8514351-B2 | Liquid crystal display | HITACHI DISPLAYS, LTD. (JP) | 2013-08-20 | — | — | US | disclosed |
| US-20130005833-A1 | PHOTO-RESPONSIVE SUPRAMOLECULAR HYDROGELS | NANJING UNIVERSITY (CN) | 2013-01-03 | — | — | US | disclosed |
| WO-2012092718-A1 | PHOTO-RESPONSIVE SUPRAMOLECULAR HYDROGELS | NANJING UNIVERSITY (CN) | 2012-07-12 | — | — | WO | disclosed |
| US-7804558-B2 | Liquid crystal display | HITACHI DISPLAYS, LTD. (JP) | 2010-09-28 | — | — | US | disclosed |
| US-20100238377-A1 | LIQUID CRYSTAL DISPLAY | MAGNOLIA PURPLE CORPORATION (JP) | 2010-09-23 | — | — | US | disclosed |
| US-20080211984-A1 | Liquid crystal display device and plasma display device | IPS ALPHA SUPPORT CO., LTD. (JP) | 2008-09-04 | — | — | US | disclosed |
| US-20070002211-A1 | Liquid crystal display | MAGNOLIA PURPLE CORPORATION (JP) | 2007-01-04 | — | — | US | disclosed |
| EP-0828709-B1 | NOVEL PHYSICALLY FUNCTIONAL MATERIALS | OPTILINK AB (SE) | 2002-09-18 | — | — | EP | disclosed |
| US-6376655-B1 | APPLYING EXTERNAL STIMULATION; OPTICAL ANISOTROPY | RISO NATIONAL LABORATORY (DK) | 2002-04-23 | — | — | US | disclosed |
| EP-1192142-A1 | CYCLO-IMINO DEPSIPEPTIDES AND THEIR UTILIZATION IN CONTROLLING ENDOPARASITES | Bayer Aktiengesellschaft (DE) | 2002-04-03 | — | — | EP | disclosed |
| WO-2000076985-A1 | CYCLO-IMINO DEPSIPEPTIDES AND THEIR UTILIZATION IN CONTROLLING ENDOPARASITES | BAYER AKTIENGESELLSCHAFT (DE) | 2000-12-21 | — | — | WO | disclosed |
| EP-0828709-A1 | NOVEL PHYSICALLY FUNCTIONAL MATERIALS | FORSKNINGSCENTER RISO (DK) | 1998-03-18 | — | — | EP | disclosed |
| WO-1996038410-A1 | NOVEL PHYSICALLY FUNCTIONAL MATERIALS | Forskningscenter Risø (DK) | 1996-12-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130005833-A1 | PHOTO-RESPONSIVE SUPRAMOLECULAR HYDROGELS | PASK, AAAS, CRYAA | AKR1B1 1019/4885LMNA 3117/4885HTT 768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.